secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2022-08-04T23:59:59+00:00
Accession:  0001906324-22-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q2 supplemental combined revenue $898.5M, adj EPS $2.12, up 123% YoY
--------------------------------------------------------------------------------

- GAAP revenue $613.4M (+247% as reported) from business combination with Ortho closed May 27, 2022.
- Supplemental combined revenue $898.5M (+37.5% constant currency); excluding COVID-19 revenue, growth 9.0%.
- GAAP diluted EPS $0.36 vs $0.45 prior year; supplemental adjusted EPS $2.12 vs $0.95 (+123%).
- Adjusted EBITDA $290.8M, margin 32.4% vs 24.8% prior year; strong double-digit growth in POC and Molecular Diagnostics.
- Foreign currency negatively impacted sales growth by ~320 bps. No formal 2022 guidance provided in release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632422000008/0001906324-22-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632422000008/qdel-20220804.htm
  HTML page:      https://secwatch.observer/filing/0001906324-22-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer